ARGX250117C660000
- 11.38
- 0.000.00%
argenx SE Newsroom
Express News | Argenx SE : Wedbush Raises Target Price to $665 From $655
Argenx Announces Approval of VYVDURA (Efgartigimod Alfa and Hyaluronidase-qvfc) in Japan for Adults With Chronic Inflammatory Demyelinating Polyneuropathy
Wells Fargo Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $723
Express News | Wells Fargo Maintains Overweight on Argenx, Raises Price Target to $723
Argenx Analyst Ratings
$1000 Invested In Argenx 5 Years Ago Would Be Worth This Much Today
Argenx Se (ARGX) Gets a Hold From UBS
Express News | Argenx : UBS Raises Target Price to $600 From $575
Leerink Partners Maintains Argenx SE(ARGX.US) With Buy Rating, Announces Target Price $635
Argenx Se: Promising Growth With Strategic Expansion and Clinical Advancements
Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved With BHV-1300, Gains Analyst Approval
Stifel Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $772
Stifel Nicolaus Keeps Their Buy Rating on Argenx Se (ARGX)
Top Gap Ups and Downs on Monday: MU, AVGO, STLA and More
Here's Why Argenx SE (ARGX) Surged in Q3
Citi Maintains Argenx SE(ARGX.US) With Buy Rating, Raises Target Price to $681
Citi Reaffirms Their Buy Rating on Argenx Se (ARGX)
Looking Into Argenx's Recent Short Interest
Should You Increase Your Holdings in Argenx SE (ARGX)?
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading